论文信息 - A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting - 字舞流文

A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

A. Troxel | M. Brose | M. Yarchoan | S. Shenoy | N. Bhat | C. Squillante | C. Grande | Zakkiyya A Posey | Anne Kathleen Harlacker | Raven Klein Yurtal | Dena M. Torrente